HEALTHTRONICS, INC. 4
4 · HEALTHTRONICS, INC. · Filed May 10, 2007
Insider Transaction Report
Form 4
SEARLES WILLIAM A
Director
Transactions
- Disposition to Issuer
Option to Purchase Common Stock
2007-05-03−50,000→ 0 totalExercise: $6.70Exp: 2016-12-05→ Common Stock (50,000 underlying) - Award
Option to Purchase Common Stock
2007-05-03+50,000→ 50,000 totalExercise: $6.70Exp: 2016-12-05→ Common Stock (50,000 underlying) - Disposition to Issuer
Option to Purchase Common Stock
2007-05-03−20,000→ 0 totalExercise: $7.79Exp: 2013-02-26→ Common Stock (20,000 underlying) - Award
Option to Purchase Common Stock
2007-05-03+20,000→ 20,000 totalExercise: $7.79Exp: 2013-02-26→ Common Stock (20,000 underlying) - Disposition to Issuer
Option to Purchase Common Stock
2007-05-03−25,000→ 0 totalExercise: $7.39Exp: 2014-12-01→ Common Stock (25,000 underlying) - Award
Option to Purchase Common Stock
2007-05-03+25,000→ 25,000 totalExercise: $7.39Exp: 2014-12-01→ Common Stock (25,000 underlying)
Footnotes (6)
- [F1]The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the option and the grant of a replacement option. The option was originally granted on February 26, 2003, was fully vested on the date of grant and under the terms of the option, the option was exercisable for a period of 90 days after termination of Mr. Searles' service as a director. On April 2, 2007, the Board of Directors of the Company, effective immediately prior to the termination of Mr. Searles' service as a director, extended the exercisability period from 90 days after such termination to until December 31, 2008.
- [F2]The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the option and the grant of a replacement option. The option was originally granted on February 19, 2004, was fully vested on the date of grant and under the terms of the option, the option was exercisable for a period of 90 days after termination of Mr. Searles' service as a director. On April 2, 2007, the Board of Directors of the Company, effective immediately prior to the termination of Mr. Searles' service as a director, extended the exercisability period from 90 days after such termination to until December 31, 2008.
- [F3]The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the option and the grant of a replacement option. The option was originally granted on December 1, 2004, was fully vested on the date of grant and under the terms of the option, the option was exercisable for a period of 90 days after termination of Mr. Searles' service as a director. On April 2, 2007, the Board of Directors of the Company, effective immediately prior to the termination of Mr. Searles' service as a director, extended the exercisability period from 90 days after such termination to until December 31, 2008.
- [F4]The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the option and the grant of a replacement option. The option was originally granted on December 1, 2005, was fully vested on the date of grant and under the terms of the option, the option was exercisable for a period of 90 days after termination of Mr. Searles' service as a director. On April 2, 2007, the Board of Directors of the Company, effective immediately prior to the termination of Mr. Searles' service as a director, extended the exercisability period from 90 days after such termination to until December 31, 2008.
- [F5]The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the option and the grant of a replacement option. The option was originally granted on December 5, 2006, with 25,000 shares vesting immediately and 25,000 shares vesting on each of the first 3 anniversaries of the date of grant. Under the terms of the option, the option was exercisable for a period of 90 days after termination of Mr. Searles' service as a director. On April 2, 2007, the Board of Directors of the Company, effective immediately prior to the termination of Mr. Searles' service as a director, (i) extended the exercisability period from 90 days after such termination to until December 31, 2008 and (ii) provided that an additional 25,000 shares would vest immediately.
- [F6]The remaining 50,000 shares covered by the option were not vested at the time of the termination of Mr. Searles' service as a director and therefore automatically expired at such time in accordance with the terms of the Company's 2004 Equity Incentive Plan and the option agreement.